相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Correlation of Fibroblast Growth Factor 23 with Cardiac Remodeling in Essential Hypertension with Normal Renal Function
Jiayu Han et al.
CARDIOLOGY (2022)
Non-ischemic dilated cardiomyopathy and cardiac fibrosis
Bianca Olivia Cojan-Minzat et al.
HEART FAILURE REVIEWS (2021)
Cardiac index predicts long-term outcomes in patients with heart failure
Tatsuro Ibe et al.
PLOS ONE (2021)
CILP1 as a biomarker for right ventricular maladaptation in pulmonary hypertension
Stanislav Keranov et al.
EUROPEAN RESPIRATORY JOURNAL (2021)
Fibroblast growth factor 23: a biomarker of fibrosis and prognosis in heart failure with preserved ejection fraction
Clotilde Roy et al.
ESC HEART FAILURE (2020)
Cardiac Magnetic Resonance Imaging-Based Right Ventricular Strain Analysis for Assessment of Coupling and Diastolic Function in Pulmonary Hypertension
Khodr Tello et al.
JACC-CARDIOVASCULAR IMAGING (2019)
FGF23, Biomarker or Target?
Cristian Rodelo-Haad et al.
TOXINS (2019)
Higher plasma fibroblast growth factor 23 levels are associated with a higher risk profile in pulmonary arterial hypertension
Habib Bouzina et al.
PULMONARY CIRCULATION (2019)
Relevance of the TAPSE/PASP ratio in pulmonary arterial hypertension
Khodr Tello et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Paracrine Effects of FGF23 on the Heart
Maren Leifheit-Nestler et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
The Relationship Between the Right Ventricle and its Load in Pulmonary Hypertension
Anton Vonk Noordegraaf et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
RV pressure overload: fromhypertrophy to failure
Cathelijne E. E. van der Bruggen et al.
CARDIOVASCULAR RESEARCH (2017)
Renocardiovascular Biomarkers: from the Perspective of Managing Chronic Kidney Disease and Cardiovascular Disease
Shinichiro Niizuma et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2017)
From Left Ventricular Hypertrophy to Dysfunction and Failure
Davide Lazzeroni et al.
CIRCULATION JOURNAL (2016)
FGF23 promotes myocardial fibrosis in mice through activation of β-catenin
Huixin Hao et al.
ONCOTARGET (2016)
Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy
Alexander Grabner et al.
CELL METABOLISM (2015)
Clinical relevance of right ventricular diastolic stiffness in pulmonary hypertension
Pia Trip et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
Roberto M. Lang et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2015)
Characteristics and Outcomes of Patients With Heart Failure and Discordant Findings by Right-Sided Heart Catheterization and Cardiopulmonary Exercise Testing
Chetan B. Patel et al.
AMERICAN JOURNAL OF CARDIOLOGY (2014)
The right ventricle in pulmonary arterial hypertension
Robert Naeije et al.
EUROPEAN RESPIRATORY REVIEW (2014)
Tricuspid annular plane systolic excursion and pulmonary arterial systolic pressure relationship in heart failure: an index of right ventricular contractile function and prognosis
M. Guazzi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2013)
Right Ventricular Diastolic Impairment in Patients With Pulmonary Arterial Hypertension
Silvia Rain et al.
CIRCULATION (2013)
Right Heart Adaptation to Pulmonary Arterial Hypertension Physiology and Pathobiology
Anton Vonk-Noordegraaf et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Associations between fibroblast growth factor 23 and cardiac characteristics in pediatric heart failure
Tamara Isakova et al.
PEDIATRIC NEPHROLOGY (2013)
Association between Circulating Fibroblast Growth Factor 23, α-Klotho, and the Left Ventricular Ejection Fraction and Left Ventricular Mass in Cardiology Inpatients
Kensaku Shibata et al.
PLOS ONE (2013)
Inorganic phosphate and FGF-23 predict outcome in stable systolic heart failure
Max Plischke et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2012)
C-terminal FGF23 is a strong predictor of survival in systolic heart failure
Damien Gruson et al.
PEPTIDES (2012)
Late gadolinium enhancement cardiovascular magnetic resonance predicts clinical worsening in patients with pulmonary hypertension
Benjamin H. Freed et al.
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE (2012)
Molecular Signature of a Right Heart Failure Program in Chronic Severe Pulmonary Hypertension
Jennifer I. Drake et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2011)
Outcomes of hospitalisation for right heart failure in pulmonary arterial hypertension
A. Campo et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
FGF23 induces left ventricular hypertrophy
Christian Faul et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of Echocardiography Endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography
Lawrence G. Rudski et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2010)
Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population
Majd A. I. Mirza et al.
ATHEROSCLEROSIS (2009)
FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis
T Shimada et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
分享论文
